Skip to main content

Table 3 Correlation between hTR, hTERT and clinicopathological parameters

From: The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters

Parameter

Freq

      

hTERT+ samples

   

hTR expression

hTERT expression

hTR expression

   

Neg.

Pos.

P

Neg.

Pos.

P

Neg.

Pos

P

Age range

≤40

>40

10 (22.2)*

35 (77.8)

0

14

10

21

0.019

0

8

10

27

0.168

0

11

10

16

0.018

Size range

≤2 cm

22 (47.8)

5

17

0.2

4

18

0.538

4

14

0.27

 

2–5 cm

19 (41.3)

9

10

 

4

15

 

7

8

 
 

>5 cm

5 (10.8)

1

4

 

0

5

 

1

4

 

Pathol.

IDC

43 (95.5)

15

28

0.593

8

35

0.798

12

23

0.602

 

ILC

1 (2.2)

0

1

 

0

1

 

0

1

 
 

Muc.

1 (2.2)

0

1

 

0

1

 

0

1

 

Grade

I

4 (9.8)

1

3

0.282

1

3

0.958

1

2

0.765

 

II

16 (39)

3

13

 

3

13

 

3

10

 
 

III

21 (51.2)

9

12

 

4

17

 

6

11

 
 

Low

20 (48.8)

4

16

0.18

4

16

1

4

12

0.7

 

High

20 (51.2)

9

12

 

4

17

 

6

11

 

ALN Inv.

Positive

26 (57.8)

6

20

0.2

4

22

0.7

5

17

0.29

 

Negative

19 (42.2)

8

11

 

4

15

 

6

9

 

Stage

I

9 (30)

4

5

0.087

2

7

0.941

3

4

0.045

 

IIA

7 (23.3)

2

5

 

2

5

 

1

4

 
 

IIB

7 (23.3)

5

2

 

1

6

 

5

1

 
 

IIIA

6 (20)

0

6

 

1

5

 

0

5

 
 

IIIB

1 (3.3)

0

1

 

0

1

 

0

1